(Photo credits: Adobe Stock – )
Monday, March 28 th
CAC 40: +0.54% to 6,589.11 points
The fact of the day
The French index opens the week up slightly in a context of tensions this evening on the geopolitical front as well as on rates, while the OAT, the 10-year French government bond, has returned to the 1% threshold for the first time since 2017. Note, across the Atlantic, the acceleration of Tesla (+7.5%): the car manufacturer will seek the agreement of its shareholders for an increase in the number of shares making up its capital. It will then proceed to a reduction of their nominal value via a distribution of dividends.
Value in sight
Split session for Orpea. After the announcement of a complaint from the State, which will request the reimbursement by the group of public aid which would have been used irregularly, the title sank by 7% in the morning. But investors finally seem to have put the threat into perspective as the stock ended up 4.5% at the top of the SBF 120 index.
Tuesday 29 March
CAC 40: +3.08% to 6,792.16 points
The fact of the day
While the first time progress seems to be made on the diplomatic front since the Russian invasion of Ukraine, investors have already wanted to plan (perhaps a little early) in the exit from the crisis. As a result, the CAC 40 rebounded vigorously in large volumes. The reaction is more measured on the American markets.
Value in sight
Carmat beats harder: +40%. The company has announced the restart of production of its artificial heart and the confirmation of the objective of a resumption of implantations in October. The medtech had voluntarily suspended them on December 2 due to quality problems that affected some of its prostheses.
Wednesday March 30
CAC 40: -0.74% to 6,741.59 points
The fact of the day
Consolidation session or good resistance for the CAC 40. We might go for the 2nd option while the decline in the index seems limited in view of international news: Russian bombardments which resume around Kyiv and inflation which explodes with our European neighbors in March, whether in Germany or Spain. Unsurprisingly, the economic sentiment index is deteriorating in Europe…
Value in sight
Abionyx Pharma soars 19% as US health authority grants orphan drug designation to biotech’s Bio-HDL CER-001.
Thursday, March 31st
CAC 40: -1.21% to 6659.87 points
The fact of the day
Concerns regarding economic conditions and the conflict in Ukraine continue to prompt investors to be cautious. The CAC 40 ends its worst quarter for two years.
Value in sight
Worldline fell by 6.65% penalized by this information from Bloomberg that Apple is working on its own payment infrastructures.
Friday April 1
CAC 40: +0.37% to 6,684.31 points
The fact of the day
Markets enter the second quarter on a cautious note, with Russia’s invasion of Ukraine, the prospect of more central bank monetary tightening and concerns regarding economic conditions continuing to weigh on the general sentiment.
Value in sight
Sodexo fell sharply (-9.46%) following saying it now expects organic growth in annual revenue “around the bottom” of the 15% to 18% range, taking into account uncertainties over COVID -19 and the war in Ukraine.
LG ([email protected])
